(Q43800251)

26 November 2017

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours (English)

1 reference

26 November 2017

1 reference

1 reference

1 reference

5

1 reference

26 November 2017

6

1 reference

26 November 2017

7

1 reference

26 November 2017

11

1 reference

26 November 2017

Astuti D

1

1 reference

26 November 2017

Agathanggelou A

2

1 reference

26 November 2017

Honorio S

3

1 reference

26 November 2017

Dallol A

4

1 reference

26 November 2017

Neumann HP

8

1 reference

26 November 2017

Voutilainen R

9

1 reference

26 November 2017

Dahia P

10

1 reference

26 November 2017

Maher ER

12

1 reference

26 November 2017

Latif F

13

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

20

1 reference

26 November 2017

7573-7577

1 reference

26 November 2017

51

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204968

26 November 2017

0 references

cites work

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Germline SDHD mutation in familial phaeochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Substrate specificities and identification of putative substrates of ATM kinase family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: a strategy for cloning the putative tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Molecular biology of neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Homozygous deletions at 3p12 in breast and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

7 January 2021

Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

7 January 2021

Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

7 January 2021

Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204968

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204968

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference